C
CELLINK
The world’s leading bioconvergence company
At a glance
- Status
- Listed
- Founded
- 2016
- Headquarters
- Göteborgs Stad, Sweden
- Listing
- IPO 2016
- Sector
- Biotech & Life Sciences
- Outcome tier
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
News
More headlines
Open roles
CELLINK in the Göteborgs Stad ecosystem
The CELLINK office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- BVBosch Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
141 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where CELLINK was the backer or acquirer, 2019–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
8 deals across CELLINK's capital deployment.
Where the deals concentrate by sector, stage, and decade.
CELLINK's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about CELLINK on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CELLINK on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


